1. Home
  2. WAY vs AXSM Comparison

WAY vs AXSM Comparison

Compare WAY & AXSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Waystar Holding Corp.

WAY

Waystar Holding Corp.

HOLD

Current Price

$32.58

Market Cap

6.7B

Sector

N/A

ML Signal

HOLD

Logo Axsome Therapeutics Inc.

AXSM

Axsome Therapeutics Inc.

HOLD

Current Price

$148.16

Market Cap

5.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WAY
AXSM
Founded
1999
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.7B
5.9B
IPO Year
2024
2015

Fundamental Metrics

Financial Performance
Metric
WAY
AXSM
Price
$32.58
$148.16
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
14
20
Target Price
$47.29
$176.00
AVG Volume (30 Days)
2.3M
519.5K
Earning Date
10-29-2025
11-03-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.62
N/A
Revenue
$1,039,842,000.00
$561,263,000.00
Revenue This Year
$16.37
$66.20
Revenue Next Year
$16.85
$57.56
P/E Ratio
$52.49
N/A
Revenue Growth
14.76
65.83
52 Week Low
$29.40
$75.56
52 Week High
$48.11
$152.94

Technical Indicators

Market Signals
Indicator
WAY
AXSM
Relative Strength Index (RSI) 39.35 56.94
Support Level $29.40 $144.00
Resistance Level $35.64 $150.00
Average True Range (ATR) 1.40 4.15
MACD -0.36 -0.73
Stochastic Oscillator 39.95 57.42

Price Performance

Historical Comparison
WAY
AXSM

About WAY Waystar Holding Corp.

Waystar Holding Corp is a provider of mission-critical cloud technology to healthcare organizations. its enterprise-grade platform transforms the complex and disparate processes comprising healthcare payments received by healthcare providers from payers and patients, from pre-service engagement through post-service remittance and reconciliation. its platform enhances data integrity, eliminates manual tasks, and improves claim and billing accuracy, which results in transparency, reduced labor costs, and faster, more accurate reimbursement and cash flow. The market for solutions extends throughout the United States and includes Puerto Rico and other USA Territories.

About AXSM Axsome Therapeutics Inc.

Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products includes AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.

Share on Social Networks: